Submitted photoA picture of Linus and Leonard Huiras in their early 20s. Both brothers died of symptoms related to Dyskeratosis Congenita, a rare hereditary disease that affects a small number of people worldwide.
Robin Huiras decided long ago that rather than sit and feel sorry for herself, she could do the exact opposite and raise awareness for the rare disease that she was born with.
Huiras life changed at age 10 when she received the news that she had Dyskeratosis Congenita (DC), a disease that affects less than one in a million people worldwide. Its a hereditary disease that was passed on to her from her fathers side of the family.
The daily battle of fighting a rare disease that is capable of destroying the human body leaves her with few options: Battle the disease quietly or help educate as many people as she can and raise money to better research it.
Huiras, who turned 40 this past March, is a 1995 New Ulm Cathedral graduate. Her dad, Linus Huiras died in June 1991 at age 43 from complications of the disease. Her uncle and Linus twin brother Leonard died in 1985 at the age of 37, also from complications of the disease. Her cousin, Joe Huiras (Leonards son), a 2002 graduate of Sleepy Eye St. Marys, also is battling the disease.
She is passionate about educating others about the disease. She became involved in a non-profit charity called Dyskeratosis Congenita, Outreach, Inc. and in 2013 she became president and helped the group do a number of activities, including sponsoring family camps and publishing a medical guidebook on the disease.
Submitted photoCousins Robin Huiras and Joe Huiras together last December. Both have Dyskeratosis Congenita, a rare hereditary disease.
She helped the group raise money and this year, for the second year in a row, she is organizing a golf tournament at the Sleepy Eye Golf Club and that will be held on Aug. 19. Last year the tournament raised more than $7,000 for the group and shes hoping to double the size of the tournament from last year.
About the disease:
Raising awareness for DC is Huiras main goal. Those with the disease usually have an increased chance of developing several life-threatening conditions, including disorders that impair bone marrow function. These disorders disrupt the ability of the bone marrow to produce new blood cells.
While the disease is capable of affecting many organs throughout the body, areas that have high rates of cell reproduction are mainly affected.
A lot of people think of it almost as an aging disease, where our aging process for our skin and our organs are accelerated, Huiras said. People that have DC a lot of times have bone marrow failure because our blood cells are one of the areas in our body that reproduce really quickly. Ninety percent of people that have DC have bone marrow failure.
Submitted photoGolfers in last years Huiras Golf Tournament Fundraiser in Sleepy Eye. The tournament raised more than $7,000 for Dyskeratosis Congenita research.golf tournament group photo cutlineParticipants in last years Huiras Golf Tournament Fundraiser in Sleepy Eye. The tournament raised more than $7,000 for Dyskeratosis Congenita research.
They are also at higher than average risk for blood cancers and have a higher risk of developing other cancers, especially cancers of the head and neck.
Oral cancer is huge, different blood cancers, different lymphomas can happen, she said. Scientists are interested in researching the disease because it can tell them a lot about the process of cancer.
Huiras noted that there are no cures for many of the complications, but there are some treatments that can slow the progression.
A lung transplant or a bone marrow transplant can be a cure for a symptom, but there is no cure for the disease, she said. Scientists are really interested in studying it, especially because of this concept of aging.
Huiras said that the diagnosis is usually made early on in a persons life. Something as simple as frequent bloody noses can be a warning sign.
Usually what happens is people get anemia and most times it happens when a person is a child, she said. There are cases when people find out when theyre an adult, they just have less severe variety of it. Kids might get bloody noses a lot, or kids might just get sick all the time and a lot of patients have poor immune systems.
Her own personal battle:
Huiras is no stranger to the complications of DC. Having battled the disease her whole life, shes had her fair share of struggles that shes encountered, none of them being an easy fix.
She started having chronic headaches at age 10 and so she went to Mayo Clinic and they did a bone marrow biopsy. There, they made the diagnosis of DC after seeing her cells were abnormal.
Despite having the disease, her teenage years were fairly normal, but she did have a few problems. She started taking prednisone daily when she was 17.
I bruised easy and my biggest thing was I couldnt run, she said. When we did the mile in gym class, that was the hardest thing for me to do.
In 1999 at the age of 22, she had an internal bleeding episode and she nearly died before she finally got to the hospital. This was a life-changer for her and she knew she had to make better decisions if she was going to continue to battle the disease.
I wasnt taking care of myself and I wasnt making the best choices, she said. I did finally go to the hospital and they were surprised I was walking and still alive. Then in my 20s, I was actually transfusion dependent, so every two months Id have to go in and get a liter of red blood cells.
She was prescribed anabolic steroids and the drugs helped her depleted bone marrow make red blood cells for a short time, but eventually those stopped working.
In December of 2005 at the age of 28 and out of options, she had a stem-cell transplant. A younger brother, who is not affected by the illness, was her stem cell donor.
She has two children and neither have DC. Her first child was born in 2008 and her second in 2012. In 2010, she had eye tear duct surgery and in 2012, she started having mild hip pain. This led to eventually having her hip joints replaced, one in January of 2017 and the other in April of 2017.
Robins battle is far from over. But shes doing fine and shes turning her attention again to helping bring awareness to the disease.
Im certainly much better than I was before, she said. I wouldnt say Im at 100 percent, but its so minor compared to the horror show that was going on before.
More than just a golf
tournament:
Robins life isnt the only in her family thats been dramatically impacted by DC. Her cousin has been fighting symptoms of the disease for nearly a decade. A stem cell transplant in 2012 at Fairview University Hospital in Minneapolis has been followed by medical ups and downs. In November 2016 Joe was diagnosed with two forms of cancer.
Not only will the Huiras golf tournament bring attention to the disease, but it will directly supporting Joe and his family, which fits the mission of DC Outreach, Huiras said.
Many of the people competing are family members, but there are many others who attended last years event to help raise money for DC.
While that was satisfying for Huiras, it was also a time where friends and families gathered to share stories of her dad and uncle.
It was like a family reunion, but what was amazing about it was we had never had an opportunity to really talk about my dad and my uncle Leonard in a way in that everyone was acknowledging of what they went through, and how it wouldve made them to know that their kids were working together to keep their memory alive, she said. It was special to have everyone in the same room to have everyone talk about their lost brothers and that was really awesome.
Some of the symptoms of
Dyskeratosis Congenita
Skin, nail and mouth changes: Abnormal dark discoloration of the skin, nails may fall off, white, thickened patches of on mucous membranes of th mouth (oral leukoplakia).
Bone marrow failure: Individuals can develop bone marrow failure marked by deficiency of the three types of blood cells (red cells, white cells, platelets)
Leukemia and cancer: Individuals can develop leukemia, especially of the head and neck.
Lung disease: Often found in patients with DC, it usually develops later than the skin abnormalities and bone marrow failure.
Excessive watery eyes
Excessive sweating of the palms and soles of the feet
Cavities and tooth loss
Narrowing of the esophagus
Urinary tract anomalies
Liver disease
Information came from: https://rarediseases.org/rare-diseases/dyskeratosis-congenita/#symptoms
2017 Huiras
Golf Tournament
August 19, Sleepy Eye Golf Course
If you go:
The tournament itself is a nine-hole scramble on August 19 at Sleepy Eye Golf Club. Registration begins at 8 a.m. And shotgun start is 8:45. You can call the Sleepy Eye Golf Club ahead of time or show up the day of to participate in the event.
The event itself costs $50 and that includes golf cart and lunch. There were 44 golfers last year who competed and there are spots for 72 this year. Money goes toward DC research and Joe Huiras medical expenses.
See the rest here:
The fight of her life - NUjournal
- Exosomes Are Being Hyped as a Silver Bullet Therapy. Scientists Say No. - Singularity Hub - December 28th, 2024
- UC Irvine Study Reveals Risks Associated with Direct-to-Consumer Ads for Stem Cell and Exosome COVID-19 Therapies - India Education Diary - November 18th, 2023
- STEM | Description, Development, & Facts | Britannica - January 31st, 2023
- What is STEM Education? | Live Science - January 31st, 2023
- Science, Technology, Engineering, and Math, including Computer Science - ed - January 23rd, 2023
- What Does STEM Stand For? Definition, Degrees and More - January 23rd, 2023
- What Is STEM? - Definition & Resources for Teachers - January 23rd, 2023
- Science, technology, engineering, and mathematics - Wikipedia - January 23rd, 2023
- Stem Definition & Meaning - Merriam-Webster - January 23rd, 2023
- November: labblood-study | News and features - University of Bristol - November 7th, 2022
- Creative Medical Technology Holdings Announces FDA Clearance of Investigational New Drug (IND) Application for AlloStem, a Novel Cell Therapy for the... - November 7th, 2022
- Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and... - November 7th, 2022
- Type 2 Diabetes Stem Cell Therapy - Top U.S. Stem Cell ... - January 1st, 2022
- Cancer Drug Approvals from 2021 That Patients May Have Missed - Curetoday.com - January 1st, 2022
- Late effects in survivors of high-risk neuroblastoma following stem cell transplant with and without total body irradiation - DocWire News - January 1st, 2022
- The new life of a teenager with a strange tumor on his face after the operation - Market Research Telecast - January 1st, 2022
- Best of what was new in diabetes health for 2021 - Dickson Post - January 1st, 2022
- Hematopoietic Stem Cell Transplantation - StatPearls ... - December 22nd, 2021
- Autologous Stem Cell Transplant for Multiple Myeloma - December 22nd, 2021
- City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society... - December 22nd, 2021
- Adaptation Is Key to Advancing Care for Adult Patients With Leukemia - OncLive - December 22nd, 2021
- FDA Approves First Drug to Prevent Graft Versus Host Disease | FDA - FDA.gov - December 22nd, 2021
- Vera Therapeutics Announces Acquisition of Monoclonal Antibody From Pfizer to Treat BK Virus in Transplant Patients - Yahoo Finance - December 22nd, 2021
- After throwing goodbye party, woman with cancer finds hope close to home in Austin - Austin American-Statesman - December 22nd, 2021
- Dr. K.M. Cherian Heart Foundation & Educational Society Organized Cme Programme & Workshop On Cell Culture And Regenerative Medicine - APN... - December 22nd, 2021
- Namesake of new center a young man in love with the pursuit of knowledge - The Saint Anselm Crier - November 7th, 2021
- Red Cross blood drive focuses on sickle cell disease fight - Palladium-Item - November 7th, 2021
- Shockwave therapy brings new healing opportunities for heart attack patients and hope for people with spinal cord injuries - KULR-TV - November 7th, 2021
- 1st CRISPR Gene Editing Trial Slated to Open in Severe SCD Patients - Sickle Cell Anemia News - April 4th, 2021
- Transplant After CD19 CAR T-Cell Therapy Shows Durable Disease Control in Children, Young Adults With B-ALL - Cancer Network - April 4th, 2021
- Timely Bone Marrow Transplant by Fortis gives new lease of life to a patient with Multiple Myeloma - APN News - April 4th, 2021
- Kirron Kher is suffering with Multiple Myeloma: Know the causes, symptoms and more about this type of blood cancer - Jagran English - April 4th, 2021
- Decitabine Improved Outcomes for Patients With Refractory Prolonged Isolated Thrombocytopenia - Hematology Advisor - April 4th, 2021
- Lake in the Hills police officer and father of 4 kids battling rare cancer forced to retire - Lake and McHenry County Scanner - April 4th, 2021
- Insulin 100: How the road to a diabetes cure is yielding better treatments - News@UofT - April 4th, 2021
- Boxcar Scars Market |Exclusive Report on Latest Trends and Market Growth Opportunities - BioSpace - April 4th, 2021
- Merck Receives Positive EU CHMP Opinion for Updated Label of KEYTRUDA (pembrolizumab) To Include Results of Phase 3 KEYNOTE-361 Trial in Certain Adult... - April 4th, 2021
- BeyondSpring Announces Submission of New Drug Application to US FDA and China NMPA for Plinabulin and G-CSF Combination for the Prevention of... - April 4th, 2021
- Types of leukemia: Prevalence, treatment options, and prognosis - Medical News Today - February 14th, 2021
- Roche receives first FDA clearance for urine sample type for BK virus quantitative test to aid in the improvement of care for transplant patients -... - February 14th, 2021
- Energy drinks may damage the heart, researchers warnshould the FDA get involved? - Cardiovascular Business - February 14th, 2021
- FDA Approves G1 Therapeutics' COSELA (trilaciclib): The First and Only Myeloprotection Therapy to Decrease the Incidence of Chemotherapy-Induced... - February 14th, 2021
- Easter Ross mum of blood cancer tot urges would-be stem cell donors to show the love this Valentine's Day; Alness lass Adeline Davidson's plight... - February 14th, 2021
- Global Induced Pluripotent Market Positive Outlook, Revenue Generation & Leading Manufacturers, Forecast 2026||CELGENE CORPORATION; Astellas... - February 14th, 2021
- Leukemia in children: Symptoms, causes, treatment, outlook, and more - Medical News Today - February 7th, 2021
- After Bone Marrow Donation Saves 9-Year-Old Boy With Cancer, Boston Mom Fights To Raise Awareness - Here And Now - February 7th, 2021
- Understanding bone marrow transplant: The guidelines and the protocols - The New Indian Express - February 4th, 2021
- Why Cynata is hopeful its COVID treatment trial will succeed where others have failed - Business News Australia - February 4th, 2021
- Mobilize family caregivers to speed the rollout of Covid-19 vaccines - STAT - February 4th, 2021
- People With Cancer Should Receive COVID-19 Vaccine, Experts Say - Cancer Health Treatment News - February 4th, 2021
- Evotec and Medical Center Hamburg-Eppendorf Enter Partnership to Develop iPSC-Based Tissue Therapy f - PharmiWeb.com - February 4th, 2021
- APOE Tied to Increased Susceptibility to SARS-CoV-2 | ALZFORUM - Alzforum - February 4th, 2021
- Transforming Outcomes in Advanced CSCC with Immunotherapy - LWW Journals - February 4th, 2021
- Ashley Cain is living his worst nightmare as his baby daughter battles leukaemia in hospital - The Sun - February 4th, 2021
- Canada's blood supply has a diversity problem and people are dying because of it - CBC.ca - February 1st, 2021
- Autologous Stem Cell and Non Stem Based therapies Market Share, Size 2021 Global Industry Future Trends, Growth, Strategies,, Segmentation, In-depth... - February 1st, 2021
- Merck Receives Positive EU CHMP Opinion for Expanded Approval of KEYTRUDA (pembrolizumab) in Certain Patients With Relapsed or Refractory Classical... - February 1st, 2021
- Merck Presents Results From Head-to-Head Phase 3 KEYNOTE-598 Trial Evaluating KEYTRUDA (pembrolizumab) in Combination With Ipilimumab Versus KEYTRUDA... - February 1st, 2021
- Disabled People Are Waiting, Anxiously, For Lifesaving Covid-19 Vaccinations - Forbes - February 1st, 2021
- Family of Belfast woman Eimear Gooderham (25) share memories and dealing with grief in special UTV programme - Belfast Telegraph - February 1st, 2021
- Single-cell molecular profiling of all three components of the HPA axis reveals adrenal ABCB1 as a regulator of stress adaptation - Science Advances - February 1st, 2021
- The Need for New Biological Targets for Therapeutic Intervention in COPD - Pulmonology Advisor - February 1st, 2021
- What Patients With Cancer, Survivors Need to Know About the Emergency Use Authorization of COVID-19 Vaccine - Curetoday.com - December 19th, 2020
- Every Patient Treated With CRISPR Gene Therapy for Blood Diseases Continues to Thrive, More Than a Year On - Good News Network - December 19th, 2020
- Are Hiccups a Sign of the New Coronavirus? - Healthline - December 19th, 2020
- KEYTRUDA Plus LENVIMA Combination Demonstrated Statistically Significant Improvement in Overall Survival, Progression-Free Survival and Objective... - December 19th, 2020
- Covid-19 can have impact on heart too, say experts - Hindustan Times - December 19th, 2020
- Even if You've Had COVID-19 You Still Need the Vaccine - Healthline - December 19th, 2020
- The Link Between Cancer and Metabolic Dysfunction - Technology Networks - December 19th, 2020
- Diamyd Medical and Critical Path Institute announce data sharing collaboration to develop advanced drug development tools in type 1 diabetes -... - December 19th, 2020
- Gene therapy gives man with sickle cell disease the chance for a better future - Science Codex - December 3rd, 2020
- Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous... - December 3rd, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - December 3rd, 2020
- Graft Versus Host Disease (GVHD) Patient Population, Treatment Algorithm, Medical Practices And Epidemiology Forecast To 2030 - The Market Feed - December 3rd, 2020
- Government of Canada and JDRF Canada announce new research funding to accelerate stem cell-based therapies for type 1 diabetes - India Education Diary - December 3rd, 2020
- Coinfection: more than the sum of its parts - Science Codex - November 19th, 2020
- Angiocrine Bioscience Announces FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to AB-205 (Universal E-CEL Cell Therapy) to... - November 17th, 2020
- FDA Approves Merck's KEYTRUDA in Combination With Chemotherapy for Patients With Locally Recurrent Unresectable or Metastatic Triple?Negative Breast... - November 17th, 2020
- Human mesenchymal stromal cells do not express ACE2 and TMPRSS2 and are not permissive to SARS-CoV-2 infection - DocWire News - November 17th, 2020
- Cleveland Clinic team draws a link between COVID-19 protection and the sleep aid melatonin - FierceBiotech - November 17th, 2020